Literature DB >> 12584602

Can preconditioning reduce laparoscopy-induced tissue injury?

S Yilmaz1, T Koken, C Tokyol, A Kahraman, G Akbulut, M Serteser, C Polat, C Gokce, O Gokce.   

Abstract

BACKGROUND: Pneumoperitoneum (P) created to facilitate laparoscopy (L) is associated with splanchnic perfusion, ischemia/reperfusion (I/R) injury, and oxidative stress. In this randomized controlled experimental study with blind outcome assessment, we evaluated the effect of preconditioning (PRE) on L-induced I/R injury.
METHODS: The subjects were 40 Sprague-Dawley male rats. P was created in all except controls, using carbondioxide (CO2) insufflation under a pressure of 15 mmHg. PRE consisted of 10 min of P, followed by 10 min of deflation (D). The rats were randomized to the following groups: Group P was subjected to 60 min of P. Group P/D was subjected to 60 min of P, followed by 45 min of D. Group PRE/P was subjected to PRE, followed by 60 min of P. Group PRE/P/D was subjected to PRE, followed by 60 min of P and 45 min of D. Group C (control) was subjected to a sham operation, without P. Its anesthesia time was equal to that for group PRE/P/D. At the end of the experiments, the rats were killed; blood, liver, and kidney samples were then obtained and coded. Plasma alanine aminotransferase (ALT) and malondialdehyde (MDA), as well as homogenized tissue MDA levels and glutathione (GSH) activities, were measured; tissue samples were assessed for histopathological evidence of injury; all assessments were done by investigators blinded to the study design. The results were decoded and analyzed statistically with the Kruskal-Wallis and Mann Whitney tests. A p <0.05 was considered significant.
RESULTS: Plasma ALT as well as plasma, liver, and kidney MDA levels and liver and kidney injury scores were increased, whereas liver and kidney GSH values were decreased in groups P and P/D, as compared to group C. Rats subjected to PRE before P had plasma ALT, kidney MDA, and kidney and liver GSH levels comparable to controls; their kidney and liver injury scores were higher than controls but significantly lower than nonpreconditioned animals. PRE enabled decreased plasma, kidney, and liver MDA as well as increased kidney GSH if applied before P; its efficacy on oxidative stress was limited to providing decreased kidney MDA and increased kidney GSH if applied before P/D. However, PRE significantly attenuated kidney and liver injury after P as well as P/D.
CONCLUSION: PRE consisting of 10 min of P followed by 10 min of D decreases the oxidative stress induced by sustained P in the plasma, liver, and kidney. PRE significantly limits liver and kidney injury after prolonged P and P/D. After further studies to define its ideal timing, PRE before L incorporating P may have clinical relevance, especially for elderly patients or those with impaired hepatic and/or renal function or perfusion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584602     DOI: 10.1007/s00464-002-9096-z

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  28 in total

1.  Alterations in hemodynamics and hepatic and splanchnic circulation during laparoscopy in rats.

Authors:  M Schäfer; H Sägesser; J Reichen; L Krähenbühl
Journal:  Surg Endosc       Date:  2001-06-12       Impact factor: 4.584

Review 2.  Kidney ischemic preconditioning.

Authors:  Joseph V Bonventre
Journal:  Curr Opin Nephrol Hypertens       Date:  2002-01       Impact factor: 2.894

3.  Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat.

Authors:  C Peralta; N Prats; C Xaus; E Gelpí; J Roselló-Catafau
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

Review 4.  The involvement of oxidative stress in the progression of renal injury.

Authors:  E Haugen; K A Nath
Journal:  Blood Purif       Date:  1999       Impact factor: 2.614

Review 5.  Reactive species mechanisms of cellular hypoxia-reoxygenation injury.

Authors:  Chuanyu Li; Robert M Jackson
Journal:  Am J Physiol Cell Physiol       Date:  2002-02       Impact factor: 4.249

6.  Loss of physiologic hepatic blood flow control ("hepatic arterial buffer response") during CO2-pneumoperitoneum in the rat.

Authors:  S Richter; A Olinger; U Hildebrandt; M D Menger; B Vollmar
Journal:  Anesth Analg       Date:  2001-10       Impact factor: 5.108

7.  Oxidative stress and reactive nitrogen species generation during renal ischemia.

Authors:  L M Walker; J L York; S Z Imam; S F Ali; K L Muldrew; P R Mayeux
Journal:  Toxicol Sci       Date:  2001-09       Impact factor: 4.849

8.  Ischaemic preconditioning ameliorates functional disturbance and impaired renal perfusion in rat ischaemia-reperfused kidneys.

Authors:  T Ogawa; Y Mimura; N Hiki; H Kanauchi; M Kaminishi
Journal:  Clin Exp Pharmacol Physiol       Date:  2000-12       Impact factor: 2.557

Review 9.  Hepatic ischemia-reperfusion injury.

Authors:  F Serracino-Inglott; N A Habib; R T Mathie
Journal:  Am J Surg       Date:  2001-02       Impact factor: 2.565

10.  Gut ischemia, oxidative stress, and bacterial translocation in elevated abdominal pressure in rats.

Authors:  E Eleftheriadis; K Kotzampassi; K Papanotas; N Heliadis; K Sarris
Journal:  World J Surg       Date:  1996-01       Impact factor: 3.352

View more
  20 in total

1.  Validation and reduction of the oxidative stress following laparoscopic operations: a prospective randomized controlled study.

Authors:  Amitai Bickel; Assi Drobot; Michael Aviram; Arie Eitan
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

2.  Filtered signal-averaged P-wave duration during pneumoperitoneum in patients undergoing laparoscopic cholecystectomy: A reflection of pathophysiological cardiac changes.

Authors:  Amitai Bickel; Michael Marinovski; Alexander Shturman; Nathan Roguin; Igor Waksman; Arie Eitan
Journal:  Surg Endosc       Date:  2007-12-11       Impact factor: 4.584

Review 3.  The potential role for xanthine oxidase inhibition in major intra-abdominal surgery.

Authors:  Anubhav Mittal; Anthony R J Phillips; Benjamin Loveday; John A Windsor
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

4.  Nitric oxide synthase inhibition aggravates the adverse renal effects of high but not low intraabdominal pressure.

Authors:  Bishara Bishara; Rawi Ramadan; Tony Karram; Hoda Awad; Niroz Abu-Saleh; Joseph Winaver; Akram Assadi; Zaid Abassi
Journal:  Surg Endosc       Date:  2009-08-26       Impact factor: 4.584

5.  Evaluation of liver enzymes following elective laparoscopic cholecystectomy: are they really elevated?

Authors:  Amitai Bickel; Alexander Weiar; Arie Eitan
Journal:  J Gastrointest Surg       Date:  2008-06-02       Impact factor: 3.452

6.  Ameliorating effects of CAPE on oxidative damage caused by pneumoperitoneum in rat lung tissue.

Authors:  Isil Davarci; Harun Alp; Tumay Ozgur; Murat Karcioglu; Kasim Tuzcu; Osman Evliyaoglu; Sedat Motor; Tulin Durgun Yetim
Journal:  Int J Clin Exp Med       Date:  2014-07-15

7.  Preconditioning-like amelioration of erythropoietin against laparoscopy-induced oxidative injury.

Authors:  E Ates; S Yilmaz; E Ihtiyar; B Yasar; E Karahuseyinoglu
Journal:  Surg Endosc       Date:  2006-02-21       Impact factor: 4.584

8.  The effect of pentoxifylline on oxidative stress in CO2 pneumoperitoneum.

Authors:  Ayhan Dinckan; Emel Sahin; Mehmet Ogus; Kemal Emek; Saadet Gumuslu
Journal:  Surg Endosc       Date:  2008-03-18       Impact factor: 4.584

9.  Acute obstructive jaundice and chronic cirrhosis protect against the adverse renal effects of pneumoperitoneum: role of nitric oxide.

Authors:  Mohammad Naffaa; Niroz Abu-Saleh; Hoda Awad; Iyad Khamaysi; Tony Karram; Zaher S Azzam; Zaid Abassi; Bishara Bishara
Journal:  Surg Endosc       Date:  2013-01-26       Impact factor: 4.584

10.  Impact of pneumoperitoneum on renal perfusion and excretory function: beneficial effects of nitroglycerine.

Authors:  Bishara Bishara; Tony Karram; Samer Khatib; Rawi Ramadan; Henry Schwartz; Aaron Hoffman; Zaid Abassi
Journal:  Surg Endosc       Date:  2008-03-25       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.